Back to the overview
Corporate News - Financial News

Xylem Reports Third Quarter 2024 Results and Narrows Full-Year Guidance

06.11.2024
Xylem Inc. reports third-quarter results. The Company’s total revenue was $2.1 billion, up one percent on a reported and organic basis, and third-quarter earnings per share were up 41 percent on a reported basis and 12 percent on an adjusted basis. Orders grew 8 percent on a reported and organic basis.

“The team delivered strong results in the quarter, with earnings at the high end of guidance, and margin expansion beating our expectations,” said Matthew Pine, Xylem’s President and CEO. “Demand remained resilient, reflected in robust orders growth in all segments, and a healthy book-to-bill. Moderated organic revenue growth in the quarter was driven largely by project timing.”

“Outperformance on margin and earnings was further reinforced by momentum in our integration of Evoqua and by initial impacts from our broader simplification efforts,” Pine continued. “Evoqua integration is ahead of schedule and synergy capture continues to accelerate, giving us confidence in closing the year above target. As a result, we are narrowing our full-year earnings guidance, with continuing focus on sustainable, high-quality earnings and profitable growth.”

Net income was $217 million, or $0.89 per share. Net income margin increased 300 basis points to 10.3 percent. These results are driven by strong operational performance. Adjusted net income was $269 million, or $1.11 per share, which excludes the impacts of amortization of acquired intangible assets, restructuring and realignment costs, gain/loss from sale of businesses, special charges, and tax-related special items.

Third-quarter adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) margin was 21.2 percent, reflecting a year-over-year increase of 140 basis points. Productivity savings and price drove the margin expansion, exceeding the impact of inflation, strategic investments and mix.

Outlook

Xylem expects full-year 2024 revenue of $8.5 billion, up approximately 15 percent on a reported basis and up approximately 5 percent on an organic basis.

Full-year 2024 adjusted EBITDA margin is expected to be approximately 20.5 percent. This results in adjusted earnings per share of $4.22 to $4.24 from the previous range of $4.18 to $4.28. Full-year free cash flow conversion to net income is expected to be at least 120 percent.

Further 2024 planning assumptions are included in Xylem’s third-quarter earnings materials. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort.

More articles on this topic

Contracts + Case Stories

Rental Bypass for Aeration Tank Delivers Reliable Performance During Upgrade

25.10.2024 -

To upgrade an aeration tank at a major wastewater treatment plant in Toulouse, France, the plant required a bypass solution that could efficiently reroute 10,000 cubic meters of water per hour. The local water utility, Eau de Toulouse Métropole, partnered with Xylem’s rental team to install a customized bypass solution that not only operated without fail but also saved energy.

Read more
Miscellaneous

Xylem Helps Understanding PFAS Treatment Technologies

07.10.2024 -

PFAS treatment is a growing area of concern for water utilities, businesses and communities, particularly as governments pass stricter regulations. Research increasingly shows the harmful effects of PFAS on humans and ecosystems. Discover how PFAS treatment technologies can provide safer drinking water and limit the amount of PFAS in the environment.

Read more